Holen Sie sich die Stockscreener-App
5.37
6.76%
0.34
Handel nachbörslich:
5.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
SELLAS Life Sciences Group (NASDAQ:SLS) Trading 9.3% HigherWhat's Next? - MarketBeat
SELLAS enrolls first patient in Phase 2 AML trial of SLS009 - Investing.com India
SLS stock in spotlight: First AML patient enrolled in phase 2 leukemia trial - MSN
SLS Stock In Spotlight: First AML Patient Enrolled In Phase 2 Leukemia Trial - Asianet Newsable
According to the latest merger agreement terms, Signature Bank shareholders will receive an equity allocation at a ratio of 2.63 shares of Esquire Financial Holdings Inc. for each share of Signature stock. - Bitget
Major Bank Ratings | Evercore ISI: Raises Ryanair target price to $80, rating upgraded to "Outperform" - Bitget
Sellas announces enrollment of first patient in Phase 2 SLS009 trial - TipRanks
SELLAS Life Sciences Group Inc. announced that the first patient has been enrolled in the clinical trial of its innovative drug SLS009 for first-line treatment of newly diagnosed acute myeloid leukemia (AML). - Bitget
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009 - The Manila Times
Sellas Life Sciences Group Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009 - marketscreener.com
SELLAS Life Sciences Group (SLS) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
SELLAS Strengthens Capital Base Through Warrant Exercises - TipRanks
Sellas Life Sciences reports $42.6 million in warrant exercise proceeds - Investing.com UK
Sellas Life Sciences reports $42.6 million in warrant exercise proceeds By Investing.com - Investing.com Australia
SELLAS Life Sciences Group (NASDAQ:SLS) Trading Down 6.2%Should You Sell? - MarketBeat
Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail
Aug Catalysts: Will SELLAS Life Sciences Group Inc benefit from seasonality2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
SLS Stock Rallies Ahead Of AML Trial Readout — ‘Pharma Bro’ Martin Shkreli Says He’s Still ‘Very Bearish,’ Predicts Drug Will Fail - Stocktwits
SELLAS Life Sciences (SLS) Is Up 18.0% After Positive AML Trial Updates – What’s Changed - Yahoo Finance
SELLAS Life Sciences Group (NASDAQ:SLS) Hits New 12-Month HighStill a Buy? - MarketBeat
SLS Stock Falls Premarket: CEO Touts GPS Leukemia Strategy, But Investors Stay Cautious As AML Trial Nears Readout - Asianet Newsable
Trade Recap: Can SELLAS Life Sciences Group Inc beat the S P 5002026 EndofYear Setup & Weekly High Potential Stock Alerts - baoquankhu1.vn
SLS Stock’s Red-Hot Streak Draws Rising Short Bets — Retail Traders Are Now Betting On A Big Pharma Buyout - Stocktwits
Assessing SELLAS Life Sciences Group (SLS) Valuation After Recent Leukemia Trial Updates - Yahoo Finance
SLS Stock Takes A Breather After Big Run: Traders Eye AML Summit Featuring Advisor For Clues On Trial Readout - Stocktwits
Sellas Life Sciences draws retail buzz on SLS009 trial momentum – stock soars in pre-market - MSN
Assessing SELLAS Life Sciences Group (SLS) Valuation After New Phase 3 REGAL Trial Progress News - simplywall.st
SLS Stock Price, Quote & Chart | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst - Seeking Alpha
SLS Stock Hits Over 3-Year High As AML Drug Trial Nears Final Readout — Wall Street Sees 30% More Upside - Stocktwits
SELLAS Life Sciences (SLS) Is Up 21.8% After REGAL Trial Clears Key Continuation ReviewWhat's Changed - simplywall.st
Wall Street Recap: Can SELLAS Life Sciences Group Inc beat the S P 500July 2025 Sentiment & Safe Entry Trade Signal Reports - baoquankhu1.vn
What's Going With SELLAS Life Sciences Stock On Wednesday? - Bitget
Bull Run: Will SELLAS Life Sciences Group Inc benefit from green energy policiesWeekly Market Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
SLS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SLS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SLS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
SLS Technical Analysis & Stock Price Forecast - Intellectia AI
Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN
Sellas Life Sciences Draws Significant Retail Buzz As Traders Eye REGAL Phase 3 Catalyst – SLS Stock Soars 15% - Asianet Newsable
SELLAS Life Sciences Group Target of Unusually Large Options Trading (NASDAQ:SLS) - MarketBeat
Stock Surge: Solstice Minerals Breakthrough at Nanadie Adventure - timothysykes.com
Why SLS stock is jumping premarket: SELLAS Life Sciences puts REGAL Phase 3 countdown back in play - Bez Kabli
SELLAS Life Sciences Group (NASDAQ:SLS) Shares Up 9.8%Here's Why - MarketBeat
Solstice Minerals Shares Surge 56% on Successful Drilling Results - StocksToTrade
Anson group discloses 4.9% SELLAS Life Sciences (SLS) stake via 13G/A - Stock Titan
Profit Review: What is the target price for Green Dot Corporation stockJuly 2025 Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):